These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9867721)

  • 1. [Topic on the theme "volume replacement". 6% HES 130/0.4 is the optimum combination].
    Diwo SB
    Anaesthesist; 1998 Sep; 47(9):815. PubMed ID: 9867721
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in European colloid solutions.
    Dieterich HJ
    J Trauma; 2003 May; 54(5 Suppl):S26-30. PubMed ID: 12768098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
    Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
    Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
    Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hetastarch during initial resuscitation from trauma.
    Ogilvie MP; Ryan ML; Proctor KG
    J Trauma; 2011 May; 70(5 Suppl):S19-21. PubMed ID: 21841562
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to 'HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial'.
    Standl T
    Eur J Anaesthesiol; 2009 Aug; 26(8):702-4. PubMed ID: 19318952
    [No Abstract]   [Full Text] [Related]  

  • 7. Limited Dosage for HES?
    Boldt J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S102-3. PubMed ID: 11753710
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock.
    Marx G; Pedder S; Smith L; Swaraj S; Grime S; Stockdale H; Leuwer M
    Crit Care Med; 2006 Dec; 34(12):3005-10. PubMed ID: 16971858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
    Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
    J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
    Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
    Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
    Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
    Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Using solutions of hydroxyethyl starch (6% HES 200/0.5 (refortan) and 6% HES 130/0.4 (voluven)) in neuroanesthesiology].
    Kondrat'ev AN; Novikov VIu; Savvina IA; Driagina NV
    Anesteziol Reanimatol; 2008; (2):27-30. PubMed ID: 18543426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid restoration of microcirculatory blood flow with hyperviscous and hyperoncotic solutions lowers the transfusion trigger in resuscitation from hemorrhagic shock.
    Wettstein R; Erni D; Intaglietta M; Tsai AG
    Shock; 2006 Jun; 25(6):641-6. PubMed ID: 16721273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How would a volume dose be transported in renal insufficiency?].
    Alscher DM
    Dtsch Med Wochenschr; 2004 Mar; 129(12):646. PubMed ID: 15011136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
    Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in blood coagulation in treatment with hydroxyethyl starch].
    Sefrin P; Rauch S; Zieglmeyer C
    Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.
    Kozek-Langenecker SA; Jungheinrich C; Sauermann W; Van der Linden P
    Anesth Analg; 2008 Aug; 107(2):382-90. PubMed ID: 18633012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach.
    Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P
    Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plasma exchange in a single center: Ibni Sina experience.
    Arslan O; Arat M; Tek I; Ayyildiz E; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.